These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 12649460)
1. Economics. How much are human lives and health worth? Kaiser J Science; 2003 Mar; 299(5614):1836-7. PubMed ID: 12649460 [No Abstract] [Full Text] [Related]
3. Economics. Wielding the data-quality cudgel. Kaiser J Science; 2003 Mar; 299(5614):1837. PubMed ID: 12649461 [No Abstract] [Full Text] [Related]
4. Environmental economics. False alarm over environmental false alarms. Pacala SW; Bulte E; List JA; Levin SA Science; 2003 Aug; 301(5637):1187-8. PubMed ID: 12947184 [No Abstract] [Full Text] [Related]
5. The use of quality-adjusted life years (QALYs) in the economic appraisal of health care. Kawachi I; Bethwaite P; Bethwaite J N Z Med J; 1990 Feb; 103(883):46-8. PubMed ID: 2106105 [No Abstract] [Full Text] [Related]
6. Perspectives of U.S. government agencies on the potential role of greater scientific understanding of low-dose radiation effects in establishing regulatory health protection guidance. Tenforde TS; Brooks AL Health Phys; 2009 Nov; 97(5):516-8. PubMed ID: 19820462 [TBL] [Abstract][Full Text] [Related]
7. Quantitative risk assessment and cost-benefit analysis for carcinogens at EPA: a critique. Perera FP J Public Health Policy; 1987; 8(2):202-21. PubMed ID: 3116042 [No Abstract] [Full Text] [Related]
8. Risk proposals of the 103rd Congress. Paxman D Drug Metab Rev; 1996; 28(1-2):245-67. PubMed ID: 8744601 [No Abstract] [Full Text] [Related]
9. Law-medicine notes. An end to federal regulation: the good, the bad, and the unnecessary. Curran WJ N Engl J Med; 1982 Mar; 306(11):653-4. PubMed ID: 6799825 [No Abstract] [Full Text] [Related]
10. Regulatory science. Changes to EPA toxicology--speed or delay? Stokstad E Science; 2008 Apr; 320(5874):304-5. PubMed ID: 18420908 [No Abstract] [Full Text] [Related]
11. Environmental regulation, cost-benefit analysis, and the discounting of human lives. Revesz RL Columbia Law Rev; 1999 May; 99(4):941-1017. PubMed ID: 10558577 [TBL] [Abstract][Full Text] [Related]
12. How might cost effectiveness, quality of life, and outcomes data be used by government regulators? Gatty B Hosp Formul; 1994 Jan; 29(1):70, 69. PubMed ID: 10131268 [No Abstract] [Full Text] [Related]
13. FTC-DOJ report affirms value of health care competition. Kertesz L AHIP Cover; 2004; 45(6):13, 71-3. PubMed ID: 15700871 [No Abstract] [Full Text] [Related]
14. Comparison analysis. Critics questioning design of effectiveness studies. DoBias M Mod Healthc; 2009 Feb; 39(8):10. PubMed ID: 19274822 [No Abstract] [Full Text] [Related]
15. Being a good environmental neighbor. Barkholz A Mich Health Hosp; 2001; 37(1):16-7. PubMed ID: 11214539 [No Abstract] [Full Text] [Related]
16. Environmental pediatrics and its impact on government health policy. Goldman L; Falk H; Landrigan PJ; Balk SJ; Reigart JR; Etzel RA Pediatrics; 2004 Apr; 113(4 Suppl):1146-57. PubMed ID: 15060212 [TBL] [Abstract][Full Text] [Related]
17. Quality of life and outcomes in healthcare management. Dunleavy B J Cardiovasc Manag; 1995; 6(2):33-6. PubMed ID: 10141595 [No Abstract] [Full Text] [Related]
18. The value of coronary heart disease care for the elderly: 1987-2002. Rosen AB; Cutler DM; Norton DM; Hu HM; Vijan S Health Aff (Millwood); 2007; 26(1):111-23. PubMed ID: 17211020 [TBL] [Abstract][Full Text] [Related]
19. Health economics--what the nephrologist should know. Palmer AJ Nephrol Dial Transplant; 2005 Jun; 20(6):1038-41. PubMed ID: 15840678 [No Abstract] [Full Text] [Related]
20. A framework for the use of genomics data at the EPA. Dix DJ; Gallagher K; Benson WH; Groskinsky BL; McClintock JT; Dearfield KL; Farland WH Nat Biotechnol; 2006 Sep; 24(9):1108-11. PubMed ID: 16964223 [No Abstract] [Full Text] [Related] [Next] [New Search]